V

Verastem
D

VSTM

4.20000
USD
-0.25
(-5.51%)
Market Closed
Volume
59,192
EPS
-3
Div Yield
-
P/E
-1
Market Cap
186,927,409
OverviewSignalsIdeasNews
Related Instruments
    A
    ADMA
    -0.450
    (-2.52%)
    17.440 USD
    C
    CTMX
    -0.01000
    (-0.91%)
    1.09000 USD
    E
    EXEL
    -0.390
    (-1.16%)
    33.280 USD
    I
    IMMP
    -0.05000
    (-2.36%)
    2.07000 USD
    I
    IONS
    0.040
    (0.11%)
    35.630 USD
    M
    MNOV
    0.04000
    (1.84%)
    2.21000 USD
    S
    SGEN
    0
    (0%)
    0.000000 USD
    T
    TGTX
    1.290
    (4.17%)
    32.200 USD
    More
News

Title: Verastem

Sector: Healthcare
Industry: Biotechnology
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer thatpromote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.